| [1] |
詹媛媛, 许馨月, 逯博文, 等. 老年2型糖尿病患者认知障碍与抑郁的相关性研究[J]. 中华老年心脑血管病杂志, 2025, 27(4): 426-430. doi:10.3969/j.issn.1009-0126.2025.04.007 .
doi: 10.3969/j.issn.1009-0126.2025.04.007
|
| [2] |
HENNEY A E, RILEY D R, O'CONNOR B, et al. Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis[J]. Diabetes Obes Metab, 2024, 26(9): 3673-3683. doi: 10.1111/dom.15708 .
doi: 10.1111/dom.15708
|
| [3] |
VILACA T, EASTELL R. Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes[J]. Curr Osteoporos Rep, 2024, 22(1): 1-10. doi: 10.1007/s11914-023-00833-3 .
doi: 10.1007/s11914-023-00833-3
|
| [4] |
潘俊曦, 田天照, 刘保新, 等. 随机森林算法预测绝经后骨质疏松症与2型糖尿病关联microRNA及其靶向基因调控作用[J]. 中国骨质疏松杂志, 2022, 28(2): 248-254. doi:10.3969/j.issn.1006-7108.2022.02.017 .
doi: 10.3969/j.issn.1006-7108.2022.02.017
|
| [5] |
GAO Z, LI Y, ZHANG Y, et al. Salvianolic Acid B Accelerates Osteoporotic Fracture Healing via LncRNA-MALAT1/miR-155-5p/HIF1A Axis[J]. Curr Stem Cell Res Ther, 2025, 20(7): 759-767. doi: 10.2174/011574888X304709240628092958 .
doi: 10.2174/011574888X304709240628092958
|
| [6] |
FANG R, CAO X, ZHU Y, et al. Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9[J]. Autoimmunity, 2022, 55(4): 254-263. doi: 10.1080/08916934.2022.2037128 .
doi: 10.1080/08916934.2022.2037128
|
| [7] |
李伟, 项芬芬, 陈思萍, 等. Asprosin在2型糖尿病合并骨质疏松患者中的变化及其与TLR4/JNK/IL-1β通路的关系[J]. 中国骨质疏松杂志, 2024, 30(1): 32-36. doi:10.3969/j.issn.1006-7108.2024.01.007 .
doi: 10.3969/j.issn.1006-7108.2024.01.007
|
| [8] |
LAOHAJAROENSOMBAT O, POOCHANASRI M, SAMAKKARNTHAI P. An update on bone in diabetes[J]. Curr Opin Endocrinol Diabetes Obes, 2025, 32(4): 142-148. doi: 10.1097/MED.0000000000000915 .
doi: 10.1097/MED.0000000000000915
|
| [9] |
尹经霞, 余丽, 蒲丹岚, 等. 《中国糖尿病防治指南(2024版)》解读[J]. 重庆医科大学学报, 2025, 50(5): 557-564. doi:10.13406/j.cnki.cyxb.003749 .
doi: 10.13406/j.cnki.cyxb.003749
|
| [10] |
中华医学会放射学分会骨关节学组, 中国医师协会放射医师分会肌骨学组, 中华医学会骨科学分会骨质疏松学组, 等. 骨质疏松的影像学与骨密度诊断专家共识[J]. 中国骨质疏松杂志, 2020, 26(9): 1249-1256. doi:10.3969/j.issn.1006-7108.2020.09.001 .
doi: 10.3969/j.issn.1006-7108.2020.09.001
|
| [11] |
中华人民共和国卫生部医政司. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社, 2006: 126-137.
|
| [12] |
常乐, 周丹微, 顾小琼. 骨质疏松症患者血清DKK-1、CTRP3水平对胸腰椎骨折的预测效能[J]. 实用医学杂志, 2025, 41(12): 1907-1912. doi:10.3969/j.issn.1006-5725.2025.12.020 .
doi: 10.3969/j.issn.1006-5725.2025.12.020
|
| [13] |
LI S, LI W, CHANG L, et al. Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes[J]. J Bone Miner Metab, 2024, 42(3): 361-371. doi: 10.1007/s00774-024-01511-9 .
doi: 10.1007/s00774-024-01511-9
|
| [14] |
SON O. Comparison of the effect of Dapagliflozin and Pioglitazone on the risk of osteoporosis in postmenopausal women with Type-2 diabetes[J]. Pak J Med Sci, 2023, 39(5): 1238-1242. doi: 10.12669/pjms.39.5.7580 .
doi: 10.12669/pjms.39.5.7580
|
| [15] |
HOU X, XING B, ZHANG G, et al. Serum Irisin is Associated with Bone Mineral Density in Postmenopausal T2dm Patients Complicated with Osteoporosis and in Mice with Diabetic Osteoporosis[J]. Curr Protein Pept Sci, 2023, 24(4): 355-363. doi: 10.2174/1389203724666230228140808 .
doi: 10.2174/1389203724666230228140808
|
| [16] |
CHEN Y, MIAO Y, ZHANG Q. Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes[J]. Osteoporos Int, 2024, 35(8): 1441-1449. doi: 10.1007/s00198-024-07126-0 .
doi: 10.1007/s00198-024-07126-0
|
| [17] |
RATHMANN W, KOSTEV K. Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: A primary care cohort study[J]. Osteoporos Int, 2024, 35(12): 2099-2106. doi: 10.1007/s00198-024-07182-6 .
doi: 10.1007/s00198-024-07182-6
|
| [18] |
MONAEI K AL, ROBERT A A, FARGHALY H, et al. Assessment of risk factors for bone fractures in patients with type 2 diabetes mellitus: A study in Saudi Arabia[J]. Diabetes Metab Syndr, 2021, 15(3): 955-961. doi: 10.1016/j.dsx.2021.04.008 .
doi: 10.1016/j.dsx.2021.04.008
|
| [19] |
王振, 郭炼锦, 梁嘉荣, 等. 骨质疏松症患者MRI脂肪定量参数联合25-羟基维生素D预测骨折风险的价值[J].实用医学杂志, 2024, 40(22): 3238-3243. doi:10.3969/j.issn.1006-5725.2024.22.020 .
doi: 10.3969/j.issn.1006-5725.2024.22.020
|
| [20] |
CIVIT-URGELL A, PEÑA E, BEJAR M T, et al. bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile[J]. Diabetologia, 2025, 68(12): 2682-2695. doi: 10.1007/s00125-025-06533-0 .
doi: 10.1007/s00125-025-06533-0
|
| [21] |
RAFIEE M, SADEGHI F, MIRZAPOUR A, et al. Association of MicroRNA-103 expression with type 2 diabetes mellitus[J]. Caspian J Intern Med, 2024, 16(1): 106-113. doi: 10.22088/cjim.16.1.106 .
doi: 10.22088/cjim.16.1.106
|
| [22] |
TALEBI S S, REZAIE S, HAJMIRI M S, et al. Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus[J]. Naunyn Schmiedebergs Arch Pharmacol, 2024, 397(11): 9149-9165. doi: 10.1007/s00210-024-03219-z .
doi: 10.1007/s00210-024-03219-z
|
| [23] |
FATIMA S, ABRAR M, SHAHID A, et al. Serum asprosin and its association with bone mineral density, oxidative stress, and osteoprotegerin levels in Pakistani women with postmenopausal osteoporosis[J]. Expert Rev Endocrinol Metab, 2025, 20(5): 427-439. doi: 10.1080/17446651.2025.2510595 .
doi: 10.1080/17446651.2025.2510595
|
| [24] |
ZHOU C, HU G, LI Y, et al. Polydatin accelerates osteoporotic bone repair by inducing the osteogenesis-angiogenesis coupling of bone marrow mesenchymal stem cells via the PI3K/AKT/GSK-3β/β-catenin pathway[J]. Int J Surg, 2025, 111(1): 411-425. doi: 10.1097/JS9.0000000000002075 .
doi: 10.1097/JS9.0000000000002075
|
| [25] |
YANG Y, ZHOU H, WANG Y, et al. Phillygenin Improves the Focal Adhesion Kinase/Glycogen Synthase Kinase 3β/β-Catenin Axis to Promote Mesenchymal Stem Cell Osteogenic Differentiation[J]. Phytother Res, 2025, 39(11): 4991-5005. doi: 10.1002/ptr.8519 .
doi: 10.1002/ptr.8519
|
| [26] |
ROOMI A B, ALI E A, NORI W, et al. Asprosin is a Reliable Predictor of Osteoporosis in Type 2 Diabetic Postmenopausal Women: A Case-Control Study[J]. Indian J Clin Biochem, 2025, 40(1): 97-104. doi: 10.1007/s12291-023-01163-y .
doi: 10.1007/s12291-023-01163-y
|